Deborah Love
Research Subjects
Research Interests
Deborah Love has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Bonnie DeLor
Pfizer Inc., New York, NY
1 shared publication - Heather Sell
Pfizer Inc., New York, NY
1 shared publication - Heather Somand
Somand Solutions Group, Dexter Michigan (former Pfizer Inc.)
1 shared publication - Julie Gouveia-Pisano
Advance Medical Engagement Lead, Pfizer Inc
1 shared publication - Sean Sullivan
Institute for Health and Productivity Management (IHPM), Scottsdale, AZ
1 shared publication
Latest Publications
- Open Access
- 10 April 2025
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 67 (8) , 601-608
Impact of Uterine Fibroid Symptoms on Functional Work Impairment Among Employed Women Working in Healthcare in the United States
Objective: Quantify the impact of uterine fibroids (UF) on work productivity among employed women in the US. Methods: Adult women working in healthcare who reported either being diagnosed with or having uterine fibroid symptoms completed a survey incorporating the Work Productivity and Activity Impairment Questionnaire specific for Uterine Fibroids. Results: Among 67 respondents (mean age 43.2 years; 43% in executive/professional roles), 84% reported receiving a UF diagnosis from a healthcare provider; 16% reported symptoms consistent with UF. Forty-nine (73%) respondents reported a mean overall work impairment score of 33% during the past week due to UF driven by presenteeism (28%) relative to absenteeism (6%). Lost productivity costs were estimated at $387/week. Conclusions: Women with UF symptoms report substantial lost productivity, driven primarily by impairment while at work, which also has economic implications.
- 10 April 2025
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 67 (8) , 601-608
Open AccessImpact of Uterine Fibroid Symptoms on Functional Work Impairment Among Employed Women Working in Healthcare in the United States
Objective: Quantify the impact of uterine fibroids (UF) on work productivity among employed women in the US. Methods: Adult women working in healthcare who reported either being diagnosed with or having uterine fibroid symptoms completed a survey incorporating the Work Productivity and Activity Impairment Questionnaire specific for Uterine Fibroids. Results: Among 67 respondents (mean age 43.2 years; 43% in executive/professional roles), 84% reported receiving a UF diagnosis from a healthcare provider; 16% reported symptoms consistent with UF. Forty-nine (73%) respondents reported a mean overall work impairment score of 33% during the past week due to UF driven by presenteeism (28%) relative to absenteeism (6%). Lost productivity costs were estimated at $387/week. Conclusions: Women with UF symptoms report substantial lost productivity, driven primarily by impairment while at work, which also has economic implications.